Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Recruiting · NCT02071134
Conditions: Parkinson's Disease
At a glance
- Research payments reported, 2025
- $515,404
- U.S. investigators named
- 19
- Sites paid
- 21
- Planned or actual enrollment
- 1,500
About the trial
- Sponsor
- Boston Scientific Corporation
- Tested
- Deep Brain Stimulation (DBS) (device)
- Dates
- Started 2014-03-04; completion 2038-12
- Results posted
- Not yet
The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease. The utilization of Image Guided Programming (IGP), and other commercially available programming features, used as planning tools for the programming of patients with Boston Scientific's Vercise DBS System are also evaluated. Additionally, the utilization of the DBS Illumina 3D feature that may be used for the programming of patients with Boston Scientific's Vercise DBS Systems is also evaluated.
From ClinicalTrials.gov, last updated 2026-10-13. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Boston Scientific Corporation reported $515,404 in research payments for this study in 2025 (150 payments).
Products named: Vercise
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Michele Tagliati, M.D. Neurology · Los Angeles, CA
- Cong Zhi Zhao, M.D. Neurology · Fresno, CA
- Seth A. Kareus, M.D. Neurology · Grand Junction, CO
- Andrew S. Kern, M.D., M.S. Neurology · Aurora, CO
- Corneliu Luca, MD Neurology · Miami, FL
- Michael S. Okun, MD Neurology · Gainesville, FL
- Theresa Zesiewicz, MD Neurology · Tampa, FL
- Neepa J. Patel, MD Neurology · Chicago, IL
- Sarah E. Zauber, M.D. Neurology · Indianapolis, IN
- Mustafa S. Siddiqui, MD Neurology · Winston Salem, NC
- Kelly L. Andrzejewski, D.O., PH.D. Neurology · Rochester, NY
- Jennifer Durphy, M.D. Neurology · Albany, NY
- Ritesh Ramdhani, M.D. Specialist · New York, NY
- Brian D. Dalm, MD Neurosurgery · Columbus, OH
- Bharathy E. Sundaram, MD Neurology · Sherman, TX
- Eleni O. Vaou, M.D. Neurology · San Antonio, TX
- Pinky Agarwal, MD Neurology · Kirkland, WA
- Jason L. Aldred, M.D. Neurology · Spokane, WA
- Yi-han Lin, M.D. Neurology · Seattle, WA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- King County Public Hospital District No 2 $227,990
- University of Miami $75,200
- Regents of the University of Colorado $27,097
- Scl Health System $16,840
- University of South Florida $16,643
- University of Washington Medical Ctr, WA $15,548
- The Ohio State University $15,543
- Inland Northwest Research LLC $14,484
- University of Florida $14,406
- Research Foundation of State Unversity of New York $12,944
- Cedars-Sinai Medical Center, CA $12,388
- Intermountain Health St. Mary's Regional Hospital, CO $12,062
- Albany Medical College $11,412
- Rush University Medical Center, IL $9,485
- University of Texas Health Science Center $8,301
- St Luke's Regional Medical Center, ID $8,196
- Wake Forest University $5,985
- Indiana University $5,081
- The Feinstein Institute for Medical Research $3,833
- Texoma Neurology Associates PA $1,371
- Rush University Medical Center $598
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.